BUROSUMAB
UNII G9WJT6RD29

Substance Identification & Data

This profile provides standardized clinical and technical data for Burosumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G9WJT6RD29.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1610833-03-8 and the RxNorm Concept ID (RxCUI) 2043855. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

G9WJT6RD29

CAS Registry Number

1610833-03-8

RxNorm Concept ID

2043855

Detailed Substance Profile

Preferred Name

BUROSUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

G9WJT6RD29

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C119744

National Cancer Institute reference terminology for clinical and research data.

INN ID

10301

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CD-40

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Burosumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.